Changeflow GovPing Healthcare & Life Sciences Zimmer Surgical Cement Recall, ANSM Safety Notice
Urgent Enforcement Amended Final

Zimmer Surgical Cement Recall, ANSM Safety Notice

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Detected
Email

Summary

ANSM registered safety action R2611180 for a lot withdrawal of Zimmer, Inc. surgical orthopedic cement (bowls and cement spatulas). The firm notified affected hospital pharmacies directly via letter dated 22/04/2026. ANSM advises users with questions to contact the issuer of the safety action directly. No product lot numbers, defect description, or patient impact data are included in the published notice.

“L'ANSM a été informée de la mise en œuvre d'une action de retrait de lot effectué par la société Zimmer, Inc.”

ANSM , verbatim from source
Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ANSM Drug & Device Safety Alerts for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 101 changes logged to date.

What changed

ANSM recorded a lot withdrawal action initiated by Zimmer, Inc. for surgical orthopedic cement products distributed to hospital pharmacies (pharmacies d'usage intérieur). The recall is logged under reference R2611180. Hospital pharmacies that received Zimmer surgical cement products should verify whether affected lots were distributed to their facility and contact Zimmer directly for return or disposal instructions. ANSM has not published lot numbers or clinical impact data in this notice, so facilities may need to request the attached firm letter for specifics.

Healthcare institutions and procurement departments managing orthopedic surgical supplies should confirm their inventory against any lot codes provided in the Zimmer correspondence. Since the recall action originates from the manufacturer rather than a regulatory mandate, the scope of affected products depends on which specific lots Zimmer identified.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Rappel n° R2611180 destiné aux pharmacies d'usage intérieur L'ANSM a été informée de la mise en œuvre d’une action de retrait de lot effectué par la société Zimmer, Inc.

Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2611180. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Téléchargez le courrier de la société Zimmer, Inc. (22/04/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Instrument
Enforcement
Branch
Executive
Source language
fr
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device recall response Product withdrawal Hospital pharmacy notification
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Public Health Healthcare

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!